DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Synechron initiates stake-sale talks with PE investors; valuation talks still evolving

Mint 1 hr ago·23 Sept 2026, 7:22 am

Synechron is reportedly in discussions with private equity firms to sell a stake in the company. This move suggests the firm is exploring ways to unlock value for its shareholders while maintaining its independence.

For investors, this news indicates the company is open to external capital, which could provide liquidity or strategic support. However, the evolving valuation talks mean the deal's terms are not yet finalized, keeping the outcome uncertain.

Investors should monitor updates on these discussions. A successful stake sale could signal confidence in the company's future, while delays or changes in valuation could impact market sentiment.